Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells.
about
BAD is a pro-survival factor prior to activation of its pro-apoptotic functionSteroid Hormone Receptor Signals as Prognosticators for Urothelial TumorProstate cancer stem cells: the role of androgen and estrogen receptorsInvolvement of the Androgen and Glucocorticoid Receptors in Bladder CancerDynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.ZEN and the art of breast health maintenance.Estrogens and prostate cancer: etiology, mediators, prevention, and management.Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies.Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation.Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.Estrogen receptor-β expression and pharmacological targeting in bladder cancer.Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer.Effects of zearalenone and alpha-Zearalenol in comparison with Raloxifene on T47D cells.Role of oestrogen receptors in bladder cancer development.Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.Involvement of Akt in mitochondria-dependent apoptosis induced by a cdc25 phosphatase inhibitor naphthoquinone analog.Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial.Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications.Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications.
P2860
Q24298421-E33ABE82-45A4-449B-8032-8C07DCAD33C2Q26771960-DF90AF88-1906-4F97-A4E7-A33CF73DB5A7Q26778415-CD9B7DEA-6E83-4206-A9BC-772A927CF021Q26782760-D2EC1FA2-341F-408C-BB48-7680A95A7852Q31065757-F02032B0-7C82-4A9C-907E-5C393166CBD5Q34238685-61529920-8253-4628-87A3-B9D0505FEC3EQ35196710-47C7A1E4-FC6B-4784-B47E-C7FC539D86D5Q36130890-D025012E-840B-41E6-9ABD-037B0EA68DC2Q36330150-BEE6A059-2D6A-43E5-93A4-184DFC1AE138Q36522049-6CB824E3-F1D1-483F-8DB6-838B4E4AE744Q36865011-D0591FFA-400C-405F-8C80-B1E20121B8C9Q37059473-04725A2E-7CB8-47BA-AD39-BD2E344F39D4Q37084590-0255E9CC-AD91-4EC0-9DD3-F31C0D551BA7Q37151639-DBB9DF4D-92B9-40BF-A86C-C9A2A617BAB5Q37329907-E93C3DA0-EB4A-4DC6-846E-4E70003698C5Q38099200-0474A116-BC52-47C9-9C2E-ACC3DF47B852Q39644350-F341876D-E288-404E-86F4-799E39C02EE0Q44673360-B110A3E9-A7D7-4133-A878-DADAEFE5A758Q46766883-06D5BAF5-BF17-4CC3-96FD-7E729B2B77D1Q46990082-EAADC7EC-ADE1-44C7-9D74-A05DFB949263Q49208785-C9E327C2-25B9-4974-8DD9-342E9D2DDD4DQ52589023-984FD70F-5CD0-40CE-8FE8-01FD20AA6844
P2860
Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Raloxifene, a mixed estrogen a ...... in TSU-PR1 human cancer cells.
@en
type
label
Raloxifene, a mixed estrogen a ...... in TSU-PR1 human cancer cells.
@en
prefLabel
Raloxifene, a mixed estrogen a ...... in TSU-PR1 human cancer cells.
@en
P2093
P356
P1476
Raloxifene, a mixed estrogen a ...... in TSU-PR1 human cancer cells.
@en
P2093
Byung Chul Kim
Do Hwan Seong
Heung Tae Kim
Isaac Yi Kim
Ja-June Jang
Seong-Jin Kim
P304
32510-32515
P356
10.1074/JBC.M202852200
P407
P577
2002-06-25T00:00:00Z